⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

WAT

Waters Corporation

Healthcare · Diagnostics & Research

404.81USD

+1.9000 (+0.47%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End07/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 404.81
P/E239.2
Dvd Ind Yld—
P/B2.62
P/S8.6
Curr EV/T12M EBITDA100.1
Mkt Cap (USD)39.7B
Curr EV (USD)44.5B
2)

Per Share Data

EPS T12M-2.11
DPS—
Bk Val Per Sh154.70
Rev/Sh0.05
Cash/Sh5.49
Curr Shares Out98.2M
FCF/Sh0.00
3)

Cash Flow Analysis

P/CF72.3
Curr P/FCF109.5
CF/NI3.3
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales11.8%
Eff Interest Rate4.9%
4)

Growth Potential

Dil EPS 1Y Gr0.5%
Cap 1Y Gr1.5%
BPS 1Y Gr39.7%
R&D To Sales6.9%
Retention Rate100.0%
Rev 1Y Gr7.0%
FCF 1Y Gr-12.9%
Assets 1Y Gr11.5%
5)

Profitability

EBITDA0.4B
EBIT0.3B
Operating Margin7.1%
Pretax Margin4.4%
Net Margin3.6%
ROA1.1%
ROE1.9%
ROC1.3%
Asset Turnover0.32
6)

Structure

Current Ratio1.86
Quick Ratio1.05
Debt/Assets19.7%
Debt/Com Eq32.2%
Net Debt/EBITDA9.77
Tot Debt/Capital24.3%
Gross Margin40.4%
EBIT/Int Exp2.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.